EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the relationship between Toll-like receptor activity, low-grade inflammation, cognitive deficits, and antipsychotic drug dose in schizophrenia patients: a moderation analysis

Saahithh Redddi Patlola iD, Brian Hallahan, Ross McManus iD, Marcus Kenyon iD, Colm McDonald iD, Derek Morris iD, John Kelly iD, Gary Donohoe, Declan P McKernan iD

Psychological Medicine · 2026 · 56

DOI: 10.1017/s0033291726103596 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychological Medicine, online erschienen am 03.03.2026. Verfasst von Saahithh Redddi Patlola und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology & Therapeutics, https://ror.org/03bea9k73School of Pharmacy & Medical Sciences, University of Galway, Ireland. Hauptthemen laut MEDLINE: Antipsychotic Agents, Schizophrenia, Cognitive Dysfunction, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Schizophrenia (SZ) is a debilitating psychiatric disorder where patients experience cognitive decline. Antipsychotic drugs alleviate positive symptoms but do not improve cognitive performance. We previously demonstrated that Toll-like receptors (TLRs), involved in cytokine production, can predict cognitive deficits in SZ patients. In this study, we aim to investigate the potential moderating effects of antipsychotic drugs on the associations between cytokines, TLRs, and cognition.

Methods

In total, 280 participants (201 controls and 79 cases of SZ) were recruited in Ireland. Venous blood from the participants was stimulated with TLR ligands. Levels of cytokines were measured from plasma and post-blood stimulation. The participants were administered a battery of cognitive tasks using the Cambridge Neuropsychological Test Automated Battery and Wechsler Adult Intelligence Scale-IIIR. Olanzapine equivalents were calculated using the defined daily dose method.

Results

The results indicate that antipsychotic drug dose does not predict TLR activity or cognition, indicating that antipsychotic drug dose does not have a direct effect on cognition or TLR activity. However, the relationship between TLR4 activity and visual learning and memory is moderated by the antipsychotic drug dose ( B = −0.065; p < 0.001), where increasing doses have a decreasing impact on their relationship.

Conclusions

Our data indicate that the dose of antipsychotic drugs alone cannot predict changes in cognitive performance and TLR4-activity. It also suggests that antipsychotic drug doses significantly affect TLR activity and its relationship with cognition. These effects are more pronounced on some domains than others. These findings open up new avenues for understanding the complex interplay between antipsychotic drugs, TLRs, and cognitive deficits in SZ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsSchizophreniaCognitive DysfunctionInflammationCytokinesToll-Like ReceptorsToll-Like Receptor 4HumansMaleFemaleAdultMiddle AgedNeuropsychological TestsIrelandDose-Response Relationship, DrugYoung Adult

Stichwörter der Autor:innen

Antipsychotic drugsToll-like receptorcognitioncytokineinflammationmoderation analysisschizophreniasocial cognition

Substanzen

Antipsychotic AgentsCytokinesToll-Like ReceptorsToll-Like Receptor 4

Autor:innen und Institutionen

  • Pharmacology & Therapeutics, https://ror.org/03bea9k73School of Pharmacy & Medical Sciences, University of Galway, Ireland.
  • Centre for Neuroimaging, Cognition and Genomics (NICOG),University of Galway, Ireland.
  • School of Medicine, University of Galway, Ireland.
  • Department of Psychiatry, https://ror.org/02tyrky19Trinity College Dublin, St. James's Hospital, Dublin, Ireland.
  • https://ror.org/02tyrky19School of Biological and Chemical Sciences, University of Galway, Ireland.
  • https://ror.org/03bea9k73School of Psychology, University of Galway, Ireland.

ORCID-Profile: Saahithh Redddi Patlola, Ross McManus, Marcus Kenyon, Colm McDonald, Derek Morris, John Kelly, Declan P McKernan

Förderung

  • H2020 European Research Council

Zitieren

APA

Patlola, S. R., Hallahan, B., McManus, R., Kenyon, M., McDonald, C., Morris, D., Kelly, J., Donohoe, G., & McKernan, D. P. (2026). Investigating the relationship between Toll-like receptor activity, low-grade inflammation, cognitive deficits, and antipsychotic drug dose in schizophrenia patients: a moderation analysis. Psychological Medicine, 56. https://doi.org/10.1017/s0033291726103596

Vancouver

Patlola SR, Hallahan B, McManus R, Kenyon M, McDonald C, Morris D, et al. Investigating the relationship between Toll-like receptor activity, low-grade inflammation, cognitive deficits, and antipsychotic drug dose in schizophrenia patients: a moderation analysis. Psychological Medicine. 2026;56. doi:10.1017/s0033291726103596

BibTeX
@article{Patlola2026,
  author = {Patlola, Saahithh Redddi and Hallahan, Brian and McManus, Ross and Kenyon, Marcus and McDonald, Colm and Morris, Derek and Kelly, John and Donohoe, Gary and McKernan, Declan P},
  title = {Investigating the relationship between Toll-like receptor activity, low-grade inflammation, cognitive deficits, and antipsychotic drug dose in schizophrenia patients: a moderation analysis},
  journal = {Psychological Medicine},
  year = {2026},
  volume = {56},
  doi = {10.1017/s0033291726103596}
}
Kostenlos starten →